Exome sequencing early in outpatient evaluation in NCGENES 2: Changing the course of the diagnostic odyssey?
{{output}}
The impact of clinical exome and genome sequencing (ES/GS) depends on the clinical setting. In the sequencing arm of a multifactor randomized clinical trial to evaluate broadening access, we assessed the diagnostic and inconclusive findings of ES as a 'first-... ...
